Form 4: Eli Lilly Executive Acquires Over $8.6M in Company Stock

Eli Lilly's EVP, General Counsel & Secretary, Anat Hakim, acquired 8,277.919 shares of common stock at $1,044.67 per share, totaling approximately $8.6 million.

Summary

• Anat Hakim, Executive Vice President, General Counsel, and Secretary of Eli Lilly & Co (LLY), acquired 8,277.919 shares of common stock.
• The transaction occurred on February 9, 2026, at a price of $1,044.67 per share.
• The total value of the acquired shares is approximately $8,649,000.00.
• Following this transaction, Anat Hakim directly beneficially owns 22,987.024 shares of common stock.
• Additionally, indirect beneficial ownership includes 15,700 shares through an Anat Hakim SLAT and 16,875 shares by her spouse.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal. Insider buying by a key executive, particularly a substantial amount, typically reflects confidence in the company's future performance and valuation, which can reassure investors.

Positives

• A senior executive's acquisition of a significant number of company shares signals strong confidence in the company's future prospects and valuation.
• The transaction being executed under a Rule 10b5-1 plan indicates a pre-planned, systematic approach to insider trading, often viewed positively for transparency and compliance.

Future Outlook

This filing does not contain specific forward-looking statements or guidance regarding the company's future performance.

Management Comments

• The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.

Industry Context

StockSavvy.ai notes that insider buying, especially by a high-ranking executive like the EVP, General Counsel, and Secretary, is often interpreted by the market as a positive signal, indicating management's belief in the company's intrinsic value and future growth prospects. This can be particularly impactful for a pharmaceutical giant like Eli Lilly, which relies heavily on R&D success and market penetration.

Corporate Governance

Related Party Transactions

• Indirect beneficial ownership includes 15,700 shares held by an Anat Hakim SLAT (Spousal Lifetime Access Trust) and 16,875 shares held by her spouse.

Stakeholder Impact

• Shareholders: The acquisition by a senior executive may instill greater confidence in the company's stock performance and future outlook.
• Employees: May view the executive's investment as a positive sign of the company's stability and growth potential.

Key Dates

Recommendation

The significant acquisition of company stock by a high-ranking executive, particularly under a Rule 10b5-1 plan, is a strong indicator of insider confidence in Eli Lilly's future prospects. This insider buying suggests that management believes the stock is undervalued or has substantial upside potential, making it a compelling signal for investors to consider a 'buy' position.

Keywords

Eli Lilly, LLY, Insider Trading, Stock Acquisition, Executive Compensation, Form 4, Rule 10b5-1